Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide
- 1 September 1995
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (6) , 861-867
- https://doi.org/10.1016/0006-2952(95)00255-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mycophenolate mofetil: Molecular mechanisms of actionPerspectives in Drug Discovery and Design, 1994
- New Immunosuppressive Drugs: Mechanistic Insights and Potential Therapeutic AdvancesImmunological Reviews, 1993
- The Development of Brequinar as an Immunosuppressive Drug for TransplantationImmunological Reviews, 1993
- Inhibition of the epidermal growth factor receptor tyrosine kinase activity by leflunomideFEBS Letters, 1993
- Effects of leflunomide (HWA 486) on expression of lymphocyte activation markersInflammation Research, 1993
- LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENTTransplantation, 1993
- Immunomodulation of proteoglycan-induced progressive polyarthritis by lefluflomideImmunopharmacology, 1992
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- Drug actions on delayed-type hypersensitivity in rats with developing and established adjuvant arthritisInflammation Research, 1990
- Pyrimidine Nucleotide Biosynthesis in Animals: Genes, Enzymes, and Regulation of UMP BiosynthesisAnnual Review of Biochemistry, 1980